Anjana Bose, PhD
- 8Articles
- 40.3KReads1
- 2002–2016Active
- 28Collaborators
- 248Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Anjana Bose, PhD, has published extensively on the treatment of major depressive disorder and schizophrenia/schizoaffective disorders. The research topics include the efficacy and safety of pharmacologic agents such as aripiprazole lauroxil, levomilnacipran sustained release, and escitalopram in both acute and maintenance phases of these conditions. Bose’s work, spanning from 2002 to 2016, encompasses randomized, double-blind, placebo-controlled clinical trials and safety evaluations. Frequent collaborators include Bernard L. Silverman, Dayong Li, Elliot W. Ehrich, Henry A. Nasrallah, and Jacqueline Zummo.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
